Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., we have a new way to treat cancer: immunotherapy. Rather than treating the cancer directly, immunotherapy trains the immune system to attack cancer.
Advertisement
Recommended Videos
Video
In this Front Row lecture, Assistant Professor Michael Erb will share his research applying chemical tools to study how chromatin, a molecular machine that plays a key role in transcription, becomes disrupted in cancer. He will discuss his research developing small molecule drugs targeting these genetic malfunctions.
WATCH NOWLike what you just watched? You can find similar content on the communities below.
BiopharmaTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Advertisement
